Application

JHVEPhoto Chinese regulators have accepted Zai Lab’s (NASDAQ:ZLAB) market application for the drug KarXT, also known as xanomeline and trospium chloride, for the treatment of schizophrenia in adults. Zai Lab…

The Company has made significant progress with the Pre-Feasibility Study (“PFS“) at the flagship project, Laguna Verde, and seen encouraging results from the Direct Lithium Extraction (“DLE”) pilot plant in…